Autres avocats qui pourraient vous intéresser
Dr. Manja Epping
As a lawyer specialising in pharmaceutical and IP law, Manja has been advising pharmaceutical and biotechnology companies, medical device manufacturers, and food producers on all matters relating to intellectual property and regulatory questions for many years.
A focus of her practice involves advising clients on contractual projects of a complex and cross-border nature, in particular, research and development cooperations, manufacturing agreements, distribution agreements, licencing agreements, as well as providing advise on all matters relating to transactions.
Afficher le CV complet
Masquer le CV complet
Voir plus
Moins
Voir plus
Moins
Carrière
| Since 2010 | Partner, Taylor Wessing |
| 2005 – 2010 | Partner, Ashurst LLP |
| 2002 – 2005 | Associate, Ashurst LLP |
| 1996 – 2002 | Associate, Taylor Wessing |
| 1993 – 1995 | Legal clerkship, Munich |
Formation
| 1998 | Doctoral degree, dissertation on a theme of international private arbitration, LMU Munich |
| 1996 | Admitted as a lawyer, Munich |
| 1995 | Second state examination, Munich |
| 1993 | First state examination, Munich |
| 1993 | Legal degree, LMU, Munich |
| 1990 | Studies in international law, University Paul Cézanne, Aix-Marseille III |
| 1989 | Law degree, University of Tübingen |
| 1988 | Law degree, University of Mainz |
Publications
Überraschungsentscheidungen, in: GRUR-Prax 2024, together with Sherin Sayed „Werbung für Arzneimittel“ auch bei Bezug zu unbestimmten Arzneimitteln gegeben, in: GRUR-Prax, 2023
|
Groupes & Associations
Deutsche Vereinigung für gewerblichen Rechtsschutz und Urheberrecht |
Langues étrangères
| English |
| French |
Actualités et publications récentes
Fusions et acquisitions d’entreprises et marchés financiers internationaux
Cliquer ici pour en savoir plus
Taylor Wessing advises Sunday Natural on the sale of a stake to CVC
16 janvier 2024
par plusieurs auteurs
Sciences de la vie et Santé
Cliquer ici pour en savoir plus
Germany as a location for pharmaceutical businesses - quo vadis, 2024?
Strategy paper by the German Federal Government on improving the regulatory framework for the pharmaceutical industry in Germany
11 janvier 2024
In-depth analysis
par Dr. Manja Epping et Irina Rebin
Brevets et innovation
Cliquer ici pour en savoir plus
JUVE Awards 2023: Taylor Wessing named "Law Firm of the Year for IP”
27 octobre 2023
par plusieurs auteurs
Contrats commerciaux et Consommation
Cliquer ici pour en savoir plus
The Long and Winding Road: (Some) EU and FDA Issues to Consider with Clinical Trials and Clinical Trial Agreements
21 septembre 2023
In-depth analysis
par Dr. Manja Epping et Irina Rebin